The company held the fourth session of the 11th board of directors and the fourth session of the 10th board of supervisors to examine and approve the 2021 semi-annual report and other motions.
Release time:
2021-09-13
News from our newspaper # February 27 , the company held the fourth meeting of the 11th board of directors to review and approve 2021 semi-annual report and its summary, the proposal on the disposal of assets by the holding subsidiary, the proposal on the appointment of the director of the audit office, the proposal on the related party transaction proposal on the signing of the framework agreement on the equity restructuring of the participating subsidiary and other 4 related reports and proposals.
2021# In the first half of the year, the company focused on the general policy of "following the law, keeping the right and bringing forth the new, changing and innovating, and continuously improving", on the basis of risk prevention and control, optimize the management system, improve operational efficiency, and maintain the smooth operation of the company. In the first half of the year, the company realized operating income17.13 .3 billion yuan, net profit 3.20 .5 billion yuan attributable to shareholders, and earnings per share 0.93 yuan. As of the end of 2021 6 , the company's total assets were 61.98 .3 billion yuan, the net assets attributable to shareholders of listed companies were 46.12 .5 billion yuan, and the net assets per share were 13.40 yuan.
Cement Plate: While doing a good job in epidemic prevention and control, the cement enterprises under the company actively carry out benchmarking management and standardized management internally, continuously promote the "three reductions and three improvements" activities, strictly control production costs, steadily implement various technological transformation work, and improve the production efficiency of enterprises; timely understand market trends externally, accurately study and judge market trends, and improve sales management mode. Daye Peak has completed more than 10 technical renovation projects such as low nitrogen combustion renovation at kiln end, dust collection system renovation at kiln end, and oil station renovation of cement mill roller press, effectively reducing consumption, improving system operation rate and reducing potential environmental protection and safety hazards. Facing the market changes, the marketing strategy was adjusted in time, and the production and sales were organized in an orderly manner under the guidance of market demand. Cement sales reached a record high. Yunnan Jianfeng strictly controls the procurement cost of raw materials by strengthening bidding management and continuously tracking the dynamic price information of purchased materials; in accordance with the requirements of the quality management system, it strengthens the quality control of raw materials and semi-finished products to ensure the quality of cement factory. Relying on the advanced second-generation new dry-process cement production line and adopting digital intelligent control technology, Guizhou Huangping Jianfeng carries out all-round intelligent management of safe production, product quality, material consumption and energy consumption, environmental protection emissions, etc. Since its commissioning, various economic indicators such as standard coal consumption, electricity consumption, operation rate and kiln time production have all reached expectations. Completed the transformation of cement large packaging, frequency conversion transformation of water diversion project and other projects, and achieved results in efficiency improvement; facing the challenges of weak investment and overcapacity in the regional market, we have increased investment in brand promotion in the terminal market and further increased the share of the core market.Pharmaceutical sector: Peak pharmaceutical products won the first bid for the national centralized procurement of drugs, olopatadine hydrochloride eye drops won the bid for the fourth batch of national centralized procurement of drugs, which is conducive to improving the market share of the product. In the first half of the year, Jianfeng Pharmaceutical and its subsidiaries made progress in a number of technological innovations and engineering constructions. The construction of the annual output of
20 .5 billion solid preparations (internationalization) project in Jinxi Production Base of Jianfeng Pharmaceutical was carried out in an orderly manner. At present, the civil engineering, mechanical and electrical installation and equipment installation and commissioning of the main project have been basically completed, and the verification and confirmation of process equipment and public system equipment and the construction of the project quality system are being carried out; new North Card and Peak North Card continue to fully implement technological transformation, upgrade on the basis of their existing pesticides and pharmaceutical intermediates, build a comprehensive research and development and production base for APIs, pharmaceutical intermediates and pesticides, and actively promote the industrial upgrading strategy of the integration of Peak Pharmaceutical APIs and preparations. Relying on the existing research and development platform and production base, Jianfeng Pharmaceutical Co., Ltd. gives full play to the enthusiasm of research and development personnel and speeds up the research and development progress of varieties under research. At present, more than 20 projects under research are in various stages of preclinical, clinical, pilot test, production declaration and consistency evaluation, and 2 projects are in Phase I clinical trials, 3 items in consistency evaluation; 2 items have been declared for production. Spike Pharmaceuticals also continues to explore new marketing business models, a comprehensive combing of product flow, and strengthen channel control.
Other sectors: Under the influence of the new coronary pneumonia epidemic, the national health care awareness is increasing, the demand for health products is gradually recovering, the peak health market expansion has achieved results, and the sales volume of health products has increased; Tianjin Peak Natural Products Company has reformed and optimized its product process, further reducing production costs while improving production capacity. Peak International Trade Phase III modern warehousing expansion project was fully delivered, warehousing and logistics business volume increased steadily, Jinhua South Station warehousing and transportation advantages into full play, warehousing and operation capacity has been improved. Peak cable by seizing the subway cable demand growth opportunities, strengthen communication with industry associations to improve visibility, to achieve revenue growth.On the same day, the company also held the fourth meeting of the tenth board of supervisors, and reviewed and approved the company's
2021semi-annual report and its summary and the related transaction proposal on the signing of a framework agreement for the reorganization of equity participation in subsidiaries. (residual fruit
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page